Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Although some variability was noted, such as a slightly older mean age at diagnosis in the tB-TNBC group, these differences did not reach statistical significance and were not consistently replicated across cohorts.

also in 111,027 other papers